A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a ...

Nagpur: A recent medical emergency in Nagpur has brought attention to a serious but often overlooked danger — ...

REVOLUTIONARY advances in stroke treatment are dramatically improving patient outcomes, offering new hope for patients and ...

Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

Clinuvel Pharmaceuticals (ASX:CUV) has reported encouraging preliminary results from its second study of afamelanotide in ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

Penumbra's thrombectomy growth and new products show promise, but high valuation at 7x 2025 revenue tempers appeal for GARP ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effecti ...

Researchers at UT Southwestern Medical Center found that tenecteplase, a newer drug, is just as safe and effective as ...

Northwell Phelps Hospital has been recertified as an Advanced Thrombectomy-Capable Stroke Center by The Joint Commission, ...

The analysis found that early support discharge took place among just nine per cent of stroke patients here in 2023. This is ...

Ireland saw an 8% rise in admissions for stroke in hospitals in 2023, according to the Irish National Audit of Stroke Care.